ARCHIVES

FDA Warns of Lymphoma Risk Associated With Breast Implants

This article is from The Cancer Letter archive.

Vol. 37 No. 04 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

BioSeek Awarded NIH SBIR For Compound Validation.

July 4, 2003

In Brief: HHS Drags Feet, NCI Considering Contract To Review Cancer Research Facility Needs

October 14, 1983

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

New Law Allows Texans To Self-Refer To M.D. Anderson

December 1, 1995

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

Rauscher Labels With Congress, Says NCI Needs More Money

May 2, 1975